World Health Energy Holdings, Inc.
World Health Energy Holdings, Inc. (WHEN) Financial Performance & Income Statement Overview
Explore the financials of World Health Energy Holdings, Inc. (WHEN), including yearly and quarterly data on income, cash flow, and balance sheets.
World Health Energy Holdings, Inc. (WHEN) Income Statement & Financial Overview
View the income breakdown for World Health Energy Holdings, Inc. WHEN across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $49391.00 | $42855.00 | $71250.00 | $19047.00 |
| Cost of Revenue | $7875.00 | $16840.00 | $51984.00 | $22866.00 |
| Gross Profit | $41516.00 | $26015.00 | $19266.00 | -$3819.00 |
| Gross Profit Ratio | $0.84 | $0.61 | $0.27 | -$0.20 |
| R&D Expenses | $301881.00 | $16507.00 | $456184.00 | $378199.00 |
| SG&A Expenses | $466351.00 | $482411.00 | $638026.00 | $752642.00 |
| Operating Expenses | $768232.00 | $498918.00 | $1.09M | $1.13M |
| Total Costs & Expenses | $776107.00 | $515758.00 | $1.15M | $1.15M |
| Interest Income | $0.00 | $0.00 | $28431.00 | $0.00 |
| Interest Expense | $4150.00 | $804987.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $4722.00 | $4785.00 | $4678.00 | $4733.00 |
| EBITDA | -$721994.00 | -$559575.00 | -$1.07M | -$1.13M |
| EBITDA Ratio | -$14.62 | -$13.06 | -$15.02 | -$59.32 |
| Operating Income | -$726716.00 | -$472903.00 | -$1.07M | -$1.13M |
| Operating Income Ratio | -$14.71 | -$11.03 | -$15.09 | -$59.57 |
| Other Income/Expenses (Net) | -$20411.00 | -$833299.00 | $28431.00 | -$7694.00 |
| Income Before Tax | -$747127.00 | -$1.31M | -$1.05M | -$1.14M |
| Income Before Tax Ratio | -$15.13 | -$30.48 | -$14.69 | -$59.98 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$699819.00 | -$1.25M | $81.53M | -$1.10M |
| Net Income Ratio | -$14.17 | -$29.09 | $1144.35 | -$57.71 |
| EPS | $0.00 | $0.00 | $0.00 | -$0.00 |
| Diluted EPS | $0.00 | $0.00 | $0.00 | -$0.00 |
| Weighted Avg Shares Outstanding | $564.30B | $540.82B | $542.71B | $523.63B |
| Weighted Avg Shares Outstanding (Diluted) | $564.30B | $540.82B | $542.71B | $523.63B |
The company's financials show resilient growth, with revenue advancing from $19047.00 in Q2 2024 to $49391.00 in Q1 2025. Gross profit remained healthy with margins at 84% in Q1 2025 compared to -20% in Q2 2024. Operating income hit -$726716.00 last quarter, sustaining a consistent -1471% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$721994.00. Net income rose to -$699819.00, while earnings per share reached $0.00. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan